You are here

Article info

Article menu

Download PDFPDF

Clinical and epidemiological research
Concise report
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients

Authors

  1. Correspondence to Takao Koike, Department of Medicine II, Hokkaido University Graduate School of Medicine N-15 W-7, Kita-ku, Sapporo 060–8638, Japan; tkoike{at}med.hokudai.ac.jp
View Full Text

Citation

Koike T, Harigai M, Inokuma S, et al
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
Annals of the Rheumatic Diseases 2011;70:2148-2151.

Publication history

  • Accepted July 17, 2011
  • First published August 17, 2011.
Online issue publication 
January 01, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl